Bio-Techne Corp (TECH)

Bio-Techne Corp records an AlphaScore of 64/100, categorizing within the Healthcare sector with a market capitalization of $11.36 billion. Essential metrics include a price-to-earnings ratio of 62.47 and a low debt-to-equity ratio of 0.14. A major strength of the company is its conservative financial leverage, as shown by the low debt-to-equity ratio. On the risk side, it demonstrates a negative revenue growth rate of -0.38%. Evidence is limited to the provided snapshot date of 2026-10-11.

Written 11/10/2026, 00:42:36 UTC · Snapshot 11/10/2026